FinServ Acquisition Corporation II News - FSRXW

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Friday's session are Pandora Media Inc. (P), Smith & Wesson Holding Corp. (SWHC...

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Friday's session are Audience Inc. (ADNC), Smith & Wesson Holding Corp. (SWHC...

Nabi, Biota Consider Former Inhibitex Executive Plumb as New CEO

By Kristin Jones Nabi Biopharmaceuticals (NABI) has entered into "advanced discussions" with flu-drug developer Biota Holdings Ltd. (BTA.AU) to...

CORRECT: Australia's Biota, Nabi Pharmaceuticals Plan Merger

Australian drug development company Biota Holdings Ltd. (BTA.AU) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a...

Australia's Biota, Nabi Pharmaceuticals Plan Merger

Australian drug development company Biota Holdings Ltd. (BTA.AU) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a...

AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited

AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited PR Newswire ALBANY, New York, April 17, 2012 ALBANY, New York...

Biota Announces Royalties from Inavir® and Relenza™ for Q4 and F2011

Biota Holdings Limited (ASX:BTA) announces that it has received written notifications from GlaxoSmithKline (GSK) regarding...

Biota Obtains US$2.9m NIH Grant for the Development of Novel Antibacterial

Biota Holdings Limited (ASX:BTA) advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded...

Biota Announces Inavir® Royalty for March 2011 Quarter

Biota Holdings Limited (ASX:BTA) advises that it has received written notification from Daiichi Sankyo that sales of Inavir® were...

Biota Announces Relenza Royalty for March 2011 quarter

Biota Holdings Limited (ASX:BTA) advises that it has received written notification from GlaxoSmithKline that Relenza sales were...

BARDA Awards Major Contract to Biota

Biota Holdings Limited (ASX:BTA) advises that the Office of Biomedical Advanced Research and Development Authority (BARDA) within...

Biota Appoints Piper Jaffray as Financial Advisor

Biota Holdings Limited (ASX:BTA) has appointed Piper Jaffray & Co as its lead financial advisor to assist the Company by:...

Glaxo Tests Intravenous Flu Drug Against Roche's Tamiflu

GlaxoSmithKline PLC (GSK) Wednesday said it had begun a pivotal study testing intravenous zanamivir against Roche Holding AG's (ROG.VX...

Inavir® Approved for Sale in Japan

Biota Holdings Limited (ASX:BTA) today announced that Daiichi Sankyo has received approval to manufacture and market Inavir®...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

FinServ Acquisition Corporation II (FSRXW)

Professional-Grade Tools, for Individual Investors.

FSRXW News

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Nabi, Biota Consider Former Inhibitex Executive Plumb as New CEO

CORRECT: Australia's Biota, Nabi Pharmaceuticals Plan Merger

Australia's Biota, Nabi Pharmaceuticals Plan Merger

AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited

Biota Announces Royalties from Inavir® and Relenza™ for Q4 and F2011

Biota Obtains US$2.9m NIH Grant for the Development of Novel Antibacterial

Biota Announces Inavir® Royalty for March 2011 Quarter

Biota Announces Relenza Royalty for March 2011 quarter

BARDA Awards Major Contract to Biota

Biota Appoints Piper Jaffray as Financial Advisor

Glaxo Tests Intravenous Flu Drug Against Roche's Tamiflu

Inavir® Approved for Sale in Japan

FSRXW Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

FinServ Acquisition Corporation II (FSRXW) News

FinServ Acquisition Corporation II (FSRXW)

Professional-Grade Tools, for Individual Investors.

FSRXW News

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Nabi, Biota Consider Former Inhibitex Executive Plumb as New CEO

CORRECT: Australia's Biota, Nabi Pharmaceuticals Plan Merger

Australia's Biota, Nabi Pharmaceuticals Plan Merger

AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited

Biota Announces Royalties from Inavir® and Relenza™ for Q4 and F2011

Biota Obtains US$2.9m NIH Grant for the Development of Novel Antibacterial

Biota Announces Inavir® Royalty for March 2011 Quarter

Biota Announces Relenza Royalty for March 2011 quarter

BARDA Awards Major Contract to Biota

Biota Appoints Piper Jaffray as Financial Advisor

Glaxo Tests Intravenous Flu Drug Against Roche's Tamiflu

Inavir® Approved for Sale in Japan

FSRXW Discussion

Your Recent History